Teva Branded Pharmaceutical Products R&d Llc

This study aimed to test a new drug called TAK-573, given with steroids and other cancer drugs, for people with multiple myeloma that came back or didn't respond to treatment. The goal was to find a safe dose and see if it helps shrink tumors. However, the trial was withdrawn bef…

This study tests an experimental drug called TEV-53408 in 50 adults with celiac disease who already follow a gluten-free diet. The goal is to see if the drug can reduce damage to the small intestine when they are intentionally exposed to small amounts of gluten. Participants will…

This study tests a new drug, TEV-48574, for people with moderate to severe ulcerative colitis or Crohn's disease. Participants who finished a previous study can join to see if the drug helps control their disease over a long period. The goal is to find the best dose to keep sympt…

This early-stage trial tests a new drug called TEV-53408 in 38 adults with vitiligo, a condition that causes white patches on the skin. The main goal is to see if the drug is safe when given as a shot under the skin. Participants will receive the drug for 24 weeks and be followed…

This study tests a new inhaler that combines two medicines (fluticasone and albuterol) to see if it can prevent severe asthma attacks better than albuterol alone. About 2,772 adults with asthma who have had a severe attack in the past year will take part. The study lasts at least…